FDA Invites to Generic Drugs Forum 2026
The U.S. Food and Drug Administration (FDA) will host the annual Generic Drugs Forum (GDF) on April 22-23, 2026. The two-day forum aims to foster the development and approval of safe, effective, and high-quality generics. It is intended for current and potential applicants for Abbreviated New Drug Applications (ANDA). The event brings together FDA professionals from all areas of the pre-ANDA and ANDA review programs. Attendees will gain practical insights and guidance on regulatory requirements. The goal is to improve the quality of applications, streamline the review process, and reduce the number of review cycles. This will enable patients to access affordable medicines faster. "This forum supports applicants in submitting complete and high-quality documentation," the FDA said in its announcement. A faster and more efficient approval process ultimately contributes to public health by ensuring the availability of affordable alternatives to branded drugs. The Generic Drugs Forum will be held both in person...
